Literature DB >> 28415873

Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.

Bruno Dietsche1, Tilo Kircher1, Irina Falkenberg1.   

Abstract

OBJECTIVE: Schizophrenia is a devastating mental disorder accompanied by aberrant structural brain connectivity. The question whether schizophrenia is a progressive brain disorder is yet to be resolved. Thus, it is not clear when these structural alterations occur and how they develop over time.
METHODS: In our selective review, we summarized recent findings from longitudinal magnetic resonance imaging studies investigating structural brain alterations and its impact on clinical outcome at different stages of the illness: (1) subjects at ultra-high risk of developing psychosis, (2) patients with a first episode psychosis, and (3) chronically ill patients. Moreover, we reviewed studies examining the longitudinal effects of medication on brain structure in patients with schizophrenia.
RESULTS: (1) Studies from pre-clinical stages to conversion showed a more pronounced cortical gray matter loss (i.e. superior temporal and inferior frontal regions) in those individuals who later made transition to psychosis. (2) Studies investigating patients with a first episode psychosis revealed a decline in multiple gray matter regions (i.e. frontal regions and thalamus) over time as well as progressive cortical thinning in the superior and inferior frontal cortex. (3) Studies focusing on patients with chronic schizophrenia showed that gray matter decreased to a greater extent (i.e. frontal and temporal areas, thalamus, and cingulate cortices)-especially in poor-outcome patients. Very few studies reported effects on white matter microstructure in the longitudinal course of the illness.
CONCLUSION: There is adequate evidence to suggest that schizophrenia is associated with progressive gray matter abnormalities particularly during the initial stages of illness. However, causal relationships between structural changes and illness course-especially in chronically ill patients-should be interpreted with caution. Findings might be confounded by longer periods of treatment and higher doses of antipsychotics or epiphenomena related to the illness.

Entities:  

Keywords:  Schizophrenia; brain structure; gray matter; longitudinal studies; white matter

Mesh:

Year:  2017        PMID: 28415873     DOI: 10.1177/0004867417699473

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  52 in total

Review 1.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 2.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

3.  A Systematic Characterization of Structural Brain Changes in Schizophrenia.

Authors:  Wasana Ediri Arachchi; Yanmin Peng; Xi Zhang; Wen Qin; Chuanjun Zhuo; Chunshui Yu; Meng Liang
Journal:  Neurosci Bull       Date:  2020-06-03       Impact factor: 5.203

4.  Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia.

Authors:  Long-Biao Cui; Yongbin Wei; Yi-Bin Xi; Alessandra Griffa; Siemon C De Lange; René S Kahn; Hong Yin; Martijn P Van den Heuvel
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 5.  Dendritic structural plasticity and neuropsychiatric disease.

Authors:  Marc P Forrest; Euan Parnell; Peter Penzes
Journal:  Nat Rev Neurosci       Date:  2018-03-16       Impact factor: 34.870

Review 6.  [Brain imaging in schizophrenia : A review of current trends and developments].

Authors:  Igor Nenadić
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

7.  Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.

Authors:  Li Yao; Fei Li; Jieke Liu; Wei Liao; Xiaojing Li; Mingli Li; Yajing Meng; Sugai Liang; Chengcheng Zhang; Xiao Yang; Qiang Wang; Xiaohong Ma; Wanjun Guo; John A Sweeney; Qiyong Gong; Su Lui; Wei Deng; Tao Li
Journal:  Neuropsychopharmacology       Date:  2019-06-04       Impact factor: 7.853

8.  Non-negative Matrix Factorization Reveals Resting-State Cortical Alpha Network Abnormalities in the First-Episode Schizophrenia Spectrum.

Authors:  Henry Phalen; Brian A Coffman; Avniel Ghuman; Ervin Sejdić; Dean F Salisbury
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-07-06

Review 9.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

10.  Cortical Gyrification, Psychotic-Like Experiences, and Cognitive Performance in Nonclinical Subjects.

Authors:  Ulrika Evermann; Christian Gaser; Bianca Besteher; Kerstin Langbein; Igor Nenadić
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.